Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Oncology Institute (TOI) Cost of Revenue (2021 - 2025)

Oncology Institute's Cost of Revenue history spans 5 years, with the latest figure at $52.7 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 50.5% year-over-year to $52.7 million; the TTM value through Dec 2025 reached $187.7 million, up 27.53%, while the annual FY2025 figure was $205.5 million, 35.89% up from the prior year.
  • Cost of Revenue reached $52.7 million in Q4 2025 per TOI's latest filing, up from $36.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $106.5 million in Q4 2024 to a low of -$71.4 million in Q4 2021.
  • Average Cost of Revenue over 5 years is $27.0 million, with a median of $34.0 million recorded in 2022.
  • The largest YoY upside for Cost of Revenue was 31151.09% in 2023 against a maximum downside of 99.63% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at -$71.4 million in 2021, then surged by 124.22% to $17.3 million in 2022, then surged by 179.64% to $48.4 million in 2023, then soared by 120.11% to $106.5 million in 2024, then tumbled by 50.5% to $52.7 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Cost of Revenue are $52.7 million (Q4 2025), $36.8 million (Q3 2025), and $51.1 million (Q2 2025).